世界の糖尿病治療用デバイス市場

Report Highlights

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

糖尿病モニタリングデバイスの世界市場は、2024年から2029年にかけて年平均成長率（CAGR）10.1%で成長し、2024年の166億ドルから2029年末までに268億ドルに成長すると予想されています。

Report Scope

This report provides an analysis of the market for diabetes monitoring devices, along with a competitive landscape and profiles of key companies that include their revenues, product portfolios and recent activities. It analyzes trends and market dynamics, including drivers, limitations, challenges, and opportunities, and discusses historical, current and potential market size. The report will enable readers to make informed decisions about the production and licensing of goods and services, as well as market developments and trends.

このレポートでは、糖尿病モニタリング機器の市場分析、競合状況、主要企業の収益、製品ポートフォリオ、最近の活動などのプロフィールを提供しています。また、推進要因、制限、課題、機会などのトレンドと市場動向を分析し、過去、現在、および潜在的な市場規模について説明しています。このレポートにより、読者は商品やサービスの生産とライセンス、および市場の発展とトレンドについて情報に基づいた決定を下すことができます。

The study segments the market by product type, including self-monitoring blood glucose (SMBG) devices such as blood glucose meter devices, blood glucose test strips, lancets and lancet devices; and continuous glucose monitoring (CGM) device products, including transmitters and receivers. A regional market analysis, including country-level analysis, is provided for all segments. The report covers only diabetes monitoring devices; diabetes therapeutic devices, which include insulin delivery systems and any other equipment used in hospitals are outside the scope of the report.

この調査では、血糖値測定装置、血糖値試験紙、ランセット、ランセット装置などの自己血糖値測定 (SMBG) 装置、送信機や受信機などの持続血糖値測定 (CGM) 装置製品など、製品タイプ別に市場を分類しています。国レベルの分析を含む地域市場分析は、すべてのセグメントで提供されています。レポートは糖尿病モニタリング装置のみを対象としており、インスリン投与システムや病院で使用されるその他の機器を含む糖尿病治療装置はレポートの対象外です。

Self-monitoring blood glucose (SMBG) devices:

– Blood glucose meter devices.

– Blood glucose test strips.

– Lancets and lancet devices.

Continuous glucose monitoring (CGM) systems:

– Sensors and transmitters.

– Receivers.

End users:

– Hospitals.

– Home care settings.

– Diagnostic centers.

Report Synopsis

Report Includes:

– 30 data tables and 47 additional tables

– An analysis of the global market for diabetes care devices, including self-glucose monitoring devices and continuous glucose monitoring systems

– Analyses of the global market trends, with market revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029

– Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type and sub-type, end user and region

– Discussion of the market potential and opportunities in the diabetes care industry, along with an analysis of the competitive environment, regulatory scenario and technological advances

– Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors

– Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies

– Patent analysis featuring key granted and published patents

– Emerging new developments and clinical trials in the diabetes care market

– Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

– Profiles of leading companies, including Abbott, Medtronic, Dexcom Inc., F. Hoffmann-La Roche Ltd., and LifeScan IP Holdings LLC.

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Market Definitions

Diabetes Mellitus

Types of Diabetes

Self-Monitoring Diabetic Care Devices

Chapter 3 Market Dynamics

Market Dynamics

Market Drivers

Increasing Prevalence of Diabetes

Increasing Aging Population

Demand for Better Personal Diabetes Management Tools

Healthcare and Reimbursement Policies

Increasing Focus on Preventive Healthcare

Market Restraints

Lack of Continuous Data

High Cost of CGMs

Limited Access in Low-Income Regions

Opportunities in the Market

Need for Diabetes Management Solutions

Partnerships

Market Challenges

Lack of Glucose Meter and CGM Accuracy

Chapter 4 Emerging Technologies and Developments

Overview

Implantable CGM Technology

AI Integration in CGM Monitoring

Non-Invasive CGM System

Clinical Trials

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown

Global Market for Diabetes Monitoring Devices, by Type

Self-Monitoring Blood Glucose (SMBG) Devices

Continuous Glucose Monitoring (CGM) Systems

Geographic Breakdown

Global Market for Diabetes Monitoring Devices, by Region

North America

Europe

Asia-Pacific

South America

Rest of the World

Chapter 6 Competitive Intelligence

Industry Scenario

Competitive Landscape

Chapter 7 Sustainability in the Diabetic Care Devices Market: An ESG Perspective

Introduction to ESG

ESG Performance Analysis

Environmental Performance

Social Performance

Governance Performance

Concluding Remarks from BCC Research

Chapter 8 Appendix

Research Methodology

References

Abbreviations

Company Profiles

ABBOTT

ACON LABORATORIES INC.

AGAMATRIX

ARKRAY INC.

• BRAUN SE

DEXCOM INC.

• HOFFMANN-LA ROCHE LTD.

I-SENS INC.

LIFESCAN IP HOLDINGS LLC.

MEDTRONIC

PHC HOLDINGS CORP.

SENSEONICS

SINOCARE

TERUMO CORP.

YPSOMED

List of Tables

Summary Table : Global Market for Diabetes Monitoring Devices, by Product Type, Through 2029

Table 1 : Blood Glucose Test Strip Manufacturers and Products

Table 2 : Blood Glucose Device Products and Manufacturers

Table 3 : Blood Glucose Lancets/Lancet Devices Products and Manufacturers

Table 4 : CGM Sensor and Transmitter Products and Manufacturers

Table 5 : CGM Receiver Products and Manufacturers

Table 6 : Diabetes Cases, by Country, 2021

Table 7 : Comparison of Eversense, Abbott, Medtronic and Dexcom CGMs

Table 8 : Selected Clinical Trials of Diabetic Care Devices

Table 9 : Global Market for Diabetes Monitoring Devices, by Type, Through 2029

Table 10 : Global Market for SMBG Devices, by Product Type, Through 2029

Table 11 : Global Market for CGM Systems, by Product Type, Through 2029

Table 12 : Global Market for Diabetes Monitoring Devices, by Region, Through 2029

Table 13 : Global Market for SMBG Devices, by Region, Through 2029

Table 14 : Global Market for Blood Glucose Test Strips, by Region, Through 2029

Table 15 : Global Market for Blood Glucose Meters/Devices, by Region, Through 2029

Table 16 : Global Market for Lancets and Lancet Devices, by Region, Through 2029

Table 17 : Global Market for CGM Systems, by Region, Through 2029

Table 18 : Global Market for Sensors and Transmitters Used in CGM Devices, by Region, Through 2029

Table 19 : Global Market for Receivers Used in CGM Devices, by Region, Through 2029

Table 20 : Global Market for Diabetes Monitoring Devices, by End User, Through 2029

Table 21 : North American Market for Diabetes Monitoring Devices, by Country, Through 2029

Table 22 : European Market for Diabetes Monitoring Devices, by Country, Through 2029

Table 23 : Asia-Pacific Market for Diabetes Monitoring Devices, by Country, Through 2029

Table 24 : South American Market for Diabetes Monitoring Devices, by Country, Through 2029

Table 25 : RoW Market for Diabetes Monitoring Devices, Through 2029

Table 26 : ESG: Environmental Performance

Table 27 : ESG: Social Impact

Table 28 : ESG: Governance Impact

Table 29 : Acronyms Used in this Report

Table 30 : Abbott: Company Snapshot

Table 31 : Abbott: Financial Performance, FY 2022 and 2023

Table 32 : Abbott: Product Portfolio

Table 33 : Abbott: News/Key Developments, 2024

Table 34 : Acon Laboratories Inc.: Company Snapshot

Table 35 : Acon Laboratories Inc.: Product Portfolio

Table 36 : AgaMatrix: Company Snapshot

Table 37 : AgaMatrix: Product Portfolio

Table 38 : Arkray Inc.: Company Snapshot

Table 39 : Arkray Inc.: Product Portfolio

Table 40 : B. Braun SE: Company Snapshot

Table 41 : B. Braun SE: Financial Performance, FY 2022 and 2023

Table 42 : B. Braun SE: Product Portfolio

Table 43 : Dexcom Inc.: Company Snapshot

Table 44 : Dexcom Inc.: Financial Performance, FY 2022 and 2023

Table 45 : Dexcom Inc.: Product Portfolio

Table 46 : Dexcom Inc.: News/Key Developments, 2022

Table 47 : F. Hoffmann-La Roche Ltd.: Company Snapshot

Table 48 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023

Table 49 : F. Hoffmann-La Roche Ltd.: Product Portfolio

Table 50 : i-SENS Inc.: Company Snapshot

Table 51 : i-SENS Inc.: Financial Performance, FY 2022 and 2023

Table 52 : i-SENS Inc.: Product Portfolio

Table 53 : i-SENS Inc: News/Key Developments, 2023

Table 54 : LifeScan IP Holdings LLC.: Company Snapshot

Table 55 : LifeScan IP Holdings LLC.: Product Portfolio

Table 56 : Medtronic: Company Snapshot

Table 57 : Medtronic: Financial Performance, FY 2023 and 2024

Table 58 : Medtronic: Product Portfolio

Table 59 : Medtronic: News/Key Developments, 2023

Table 60 : PHC Holdings Corp.: Company Snapshot

Table 61 : PHC Holdings Corp.: Financial Performance, FY 2022 and 2023

Table 62 : PHC Holdings Corp.: Product Portfolio

Table 63 : Senseonics: Company Snapshot

Table 64 : Senseonics: Financial Performance, FY 2022 and 2023

Table 65 : Senseonics: Product Portfolio

Table 66 : Senseonics: News/Key Developments, 2022

Table 67 : Sinocare: Company Snapshot

Table 68 : Sinocare: Financial Performance, FY 2022 and 2023

Table 69 : Sinocare: Product Portfolio

Table 70 : Sinocare: News/Key Developments, 2024

Table 71 : Terumo Corp: Company Snapshot

Table 72 : Terumo Corp.: Financial Performance, FY 2022 and 2023

Table 73 : Terumo Corp: Product Portfolio

Table 74 : Ypsomed: Company Snapshot

Table 75 : Ypsomed: Financial Performance, FY 2022 and 2023

Table 76 : Ypsomed: Product Portfolio

List of Figures

Summary Figure A : Global Market for Diabetes Monitoring Devices, by Product Type, 2021–2029

Summary Figure B : Share of Global Market for Diabetes Monitoring Devices, by Product Type, 2023

Figure 1 : Snapshot of the Market Dynamics for Diabetic Care Devices

Figure 2 : Worldwide Diabetes Cases

Figure 3 : Emerging Trends and Technologies in Diabetes Monitoring Devices

Figure 4 : Share of Global Market for Diabetes Monitoring Devices, by Type, 2023

Figure 5 : Share of Global Market for SMBG Devices, by Product Type, 2023

Figure 6 : Share of Global Market for CGM Systems, by Product Type, 2023

Figure 7 : Share of Global Market for Diabetes Monitoring Devices, by Region, 2023

Figure 8 : Share of Global Market for SMBG Devices, by Region, 2023

Figure 9 : Share of Global Market for Blood Glucose Test Strips, by Region, 2023

Figure 10 : Share of Global Market for Blood Glucose Meters/Devices, by Region, 2023

Figure 11 : Share of Global Market for Lancets and Lancet Devices, by Region, 2023

Figure 12 : Share of Global Market for CGM Systems, by Region, 2023

Figure 13 : Share of Global Market for Sensors and Transmitters Used in CGM Devices, by Region, 2023

Figure 14 : Share of Global Market for Receivers Used in CGM Devices, by Region, 2023

Figure 15 : Share of North American Market for Diabetes Monitoring Devices, by Country, 2023

Figure 16 : Share of European Market for Diabetes Monitoring Devices, by Country, 2023

Figure 17 : Share of Asia-Pacific Market for Diabetes Monitoring Devices, by Country, 2023

Figure 18 : Share of South American Market for Diabetes Monitoring Devices, by Country, 2023

Figure 19 : Share of Global Market for Diabetes Monitoring Devices, by Company, 2023

Figure 20 : Three Pillars of ESG

Figure 21 : Advantages of ESG for Companies

Figure 22 : Abbott: Revenue Share, by Business Unit, FY 2023

Figure 23 : Abbott: Revenue Share, by Country/Region, FY 2023

Figure 24 : B. Braun SE: Revenue Share, by Business Unit, FY 2023

Figure 25 : B. Braun SE: Revenue Share, by Country/Region, FY 2023

Figure 26 : Dexcom Inc.: Revenue Share, by Country/Region, FY 2023

Figure 27 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023

Figure 28 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023

Figure 29 : i-SENS Inc.: Revenue Share, by Business Unit, FY 2023

Figure 30 : i-SENS Inc.: Revenue Share, by Country/Region, FY 2023

Figure 31 : Medtronic: Revenue Share, by Business Unit, FY 2024

Figure 32 : Medtronic: Revenue Share, by Country/Region, FY 2024

Figure 33 : PHC Holdings Corp.: Revenue Share, by Business Unit, FY 2023

Figure 34 : PHC Holdings Corp.: Revenue Share, by Country/Region, FY 2023

Figure 35 : Senseonics: Revenue Share, by Country/Region, FY 2023

Figure 36 : Sinocare: Revenue Share, by Business Unit, FY 2023

Figure 37 : Sinocare: Revenue Share, by Country/Region, FY 2023

Figure 38 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023

Figure 39 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023

Figure 40 : Ypsomed: Revenue Share, by Business Unit, FY 2023

Figure 41 : Ypsomed: Revenue Share, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• バイオプラスチックの世界市場と技術 2025-03-07
• 半導体製造調査レビュー　2024年 2025-03-06
• 航空宇宙用先端材料の世界市場 2025-03-05
• 臨床試験インフラの地域別分析：中東と北アフリカ 2025-03-05
• エピジェネティクスの技術と世界市場 2025-03-04

BCC Research  出版レポート一覧